Eric A. Tanifum, PhD
Department or Service
- Texas Medical Center
Texas Children's Hospital
Assistant Professor, Baylor College of Medicine
|University of Buea||bachelors||Bachelor of Science in Chemistry||1996|
|University of Dschang||masters||Master of Science in Chemistry||1998|
|Utah State University||PhD||Organic Chemistry||2006|
|Utah State University||post-doctoral fellow||Bioorganic Chemistry||2008|
|University of Texas Medical Branch in Galveston||post-doctoral fellow||Medicinal Chemistry and Small Molecule Library Development||2009|
|The University of Texas Health Science Center at Houston||post-doctoral fellow||Nanomedicine||2011|
Dr. Tanifum received BS and MS degrees in Chemistry from the Universities of Buea and Dschang in Cameroon respectively. He moved to the US in 2001, where he earned a Ph.D. in Organic Chemistry from Utah State University in 2006. Upon graduation, he conducted postdoctoral research in bioorganic chemistry at the same institution, and medicinal chemistry and small molecule library development at the University of Texas Medical Branch in Galveston. From there he moved to The University of Texas Health Science Center at Houston were he completed a two year fellowship in nanomedicine. He joined the Edward B Singleton Department of Pediatric Radiology as a senior research scientist in 2011, and was appointed assistant professor at Baylor College of Medicine in 2013.
His previous research efforts have resulted in the development of facile chemistries for the preparation of several complex bioactive molecules, small molecule libraries for the NIH Molecular Libraries-Small Molecule Repository, and one biotech startup company. His current research efforts are focused on the development of nanoparticle-based neuroimaging technologies with emphasis on the early detection of Alzheimer’s disease pathologies, novel near-IR dyes, 19F MRI contrast agents and targeted theranostics.
1. Tanifum EA, Starosolski ZA, Fowler SW, Jankowsky JL, Annapragada AV. Cerebral vascular leak in a mouse model of amyloid neuropathy. J Cereb Blood Flow 2014, 34(10): 1646-54
2. Tanifum EA, Dasgupta I, Srivastava M, Bhavane RC, Sun L, Berridge J, Pourgarzham H, Kamath R, Espinosa G, Cook SC, Eriksen JL, Annapragada A. Intravenous delivery of targeted liposomes to amyloid-β pathology in APP/PSEN1 transgenic mice. PLoS ONE, 2012, 7(10), e48515.
3. Dasgupta I, Tanifum EA, Srivastava M, Phatak SS, Cavasotto CN, Analoui M, Annapragada A. Non inflammatory boronate based glucose-responsive insulin delivery systems. PLoS ONE, 2012, 7(1), e29585